tirzepatide ema approval The European Medicines Agency has recommended the first oral GLP-1 treatment for weight management, offering an alternative to weekly injections. Find out more in link in bio! #OneHealthEU #EMA EMA 2025: 38 Novel Drugs

If your insurance plan denies coverage for brand-name GLP-1s, you must pay the full retail pharmacy price of the drug out-of-pocket (ranging from $1,099 to $1,999/mo)

FDA-approved Mounjaro (tirzepatide) is a GLP-1 medication used for treating diabetes in adults who have a body mass index (BMI) over 27, have hypertension or dyslipidemia, or are obese ( BMI over 30)

Choosing the wrong peptides can put your health at risk and prevent you from experiencing the full benefits of therapy

Given these benefits, GLP-1s are a powerful tool in the fight against obesity and metabolic dysfunction and have revolutionized treatments

His breathing suddenly felt labored